Wellington Management Group
SPRB

Wellington Management Group’s Spruce Biosciences SPRB Stock Holding History

Wellington Management Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.19M Sell
48,796
-10,153
-17% -$700K ﹤0.01% 1477
2025
Q4 		$5.14M Buy
+58,949
New +$6.32M ﹤0.01% 1410

Other funds holding SPRB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Wellington Management Group's SPRB Position: Q1 2026 in Review

Wellington Management Group reduced its Spruce Biosciences (SPRB) stake by 17% in Q1 2026, selling an estimated $700K and leaving 48,796 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Wellington Management Group first reported a position in SPRB in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.14M in Q4 2025. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Wellington Management Group held 48,796 shares of Spruce Biosciences worth $3.19M as of Q1 2026.
  • Wellington Management Group sold 10,153 Spruce Biosciences shares in Q1 2026, an estimated $700K.
  • Spruce Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1477 holding.
  • Wellington Management Group first reported a position in Spruce Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Wellington Management Group's Spruce Biosciences position peaked at $5.14M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.